Evidence map›Paper›PMID 39950848›Full record

ArticleACS applied bio materials2025

Periodate-Mediated Cross-Linking for the Preparation of Catechol Conjugated Albumin Nanoparticles Used for in Vitro Drug Delivery.

Eda Argitekin, Ozlem Erez, Gulcin Cakan-Akdogan, Yasar Akdogan

Abstract read
In one paragraph

Article in ACS applied bio materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Recycled Sericin Biopolymer in Biotechnology and Bioelectronics.Bioengineering (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eda ArgitekinMaterials Science and Engineering Department, Izmir Institute of Technology, Izmir 35430, Turkey.
Ozlem ErezIzmir Biomedicine and Genome Center, 35340 Izmir, Turkey.ORCID 0009-0004-2020-4008
Gulcin Cakan-AkdoganIzmir Biomedicine and Genome Center, 35340 Izmir, Turkey.ORCID 0000-0002-6356-5979
Yasar AkdoganMaterials Science and Engineering Department, Izmir Institute of Technology, Izmir 35430, Turkey.ORCID 0000-0002-2465-8873

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conjugation of serum albumin protein with catechol-containing dopamine molecules provides an alternative method for the preparation of albumin nanoparticles (NPs). A commonly used desolvation method utilizes glutaraldehyde as a cross-linking agent. Here, the catechol cross-linking mechanism is used instead of glutaraldehyde providing advantages to prevent toxicity and an undesirable reaction of glutaraldehyde with cargo molecules. Covalent cross-linking between dopamine conjugated bovine serum albumin (D-BSA) proteins was obtained in the presence of sodium periodate (NaIO

Indexed as

Antibiotics, AntineoplasticBiocompatible MaterialsCatecholsDoxorubicinDrug CarriersDrug Delivery SystemsNanoparticlesSerum Albumin, BovineAnimalsCattleCell SurvivalCross-Linking ReagentsDrug LiberationDrug Screening Assays, AntitumorHumansMaterials TestingAntibiotics, AntineoplasticBiocompatible MaterialscatecholCatecholsCross-Linking ReagentsDoxorubicinDrug CarriersSerum Albumin, Bovinealbumin nanoparticlesCatechol conjugationcatechol cross-linkingdrug carrierperiodate

Identifiers

PMID39950848
PMCPMC11931531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.